Feed excerpt — reported by Fortune
Yosemite has closed its cancer-focused second fund at $350 million, a serious jump from January’s first close at $200 million, investor Reed Jobs exclusively told Fortune.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Fortune →